By GINA KOLATA
NYT Health
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
Published date: October 2, 2018 at 03:00AM
вторник, 2 октомври 2018 г.
New Your Times - Health - These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them?
By GINA KOLATA
NYT Health
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
Published date: October 2, 2018 at 03:00AM
Абонамент за:
Коментари за публикацията (Atom)
Няма коментари:
Публикуване на коментар